Search Results for: London

February 1, 2019February 1, 2019

Should NICE reconsider the 2016 UK guidelines on TB contact tracing? A cost-effectiveness analysis of contact investigations in London.

Publication date: Feb 01, 2019 In January 2016, clinical TB guidance in the UK changed to no longer recommend screening contacts of non-pulmonary, non-laryngeal (ETB) index cases. However, no new ... Read more

December 6, 2019December 6, 2019

Biobanking Can Boost Scientific Productivity

Precision Medicine News

Publication date: Dec 06, 2019 The word -biobank” will probably always conjure images of frost-covered samples tucked inside laboratory-grade freezers. Not so long ago, biological and medical researchers collected tissue ... Read more

December 6, 2019December 6, 2019

Cutting neurodegeneration associated with dementia, in animal models

Parkinson's Disease News

Publication date: Nov 26, 2019 The Korea Brain Research Institute (KBRI, President Pann Ghill Suh) announced on November 12 that korean research team made up of Dr. Hyung-Jun Kim and ... Read more

December 6, 2019December 6, 2019

Though safe, nilotinib does not show promise for benefit for Parkinson’s disease

Parkinson's Disease News

Publication date: Dec 06, 2019 Credit: Wikipedia Northwestern University and the Parkinson Study Group announced that the Nilotinib in Parkinson’s Disease (NILO-PD) study showed that nilotinib, an FDA-approved treatment for ... Read more

December 5, 2019December 5, 2019

Asia-wide genome mapping project reveals insights into Asian ancestry and genetic diversity

Precision Medicine News

Publication date: Dec 05, 2019 IMAGE: (Left to right) NTU Assistant Professor Hie Lim Kim, NTU Professor Stephan Schuster and GenomeAsia 100K Executive Chairman Mahesh Pratapneni, with the analysis of ... Read more

December 4, 2019December 4, 2019

Mission and AbbVie’s Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Milestone

Parkinson's Disease News

Publication date: Dec 04, 2019 Mission Therapeutics (-Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), and AbbVie (-AbbVie”)(ABBV), a global, research-driven biopharmaceutical company, today ... Read more

December 2, 2019December 2, 2019

Wellcome Trust establishes first Translational Partnership in Germany – with the BIH and Charité

Precision Medicine News

Publication date: Dec 02, 2019 The Berlin Institute of Health (BIH) and CharitcE9 – UniversitcE4tsmedizin Berlin are the first institutions in Germany to receive funding to create a translational partnership ... Read more

November 29, 2019November 29, 2019

Professor Tom Foltynie – Bydureon: Phase III Trial

Parkinson's Disease Media

Publication date: Nov 28, 2019 Professor Tom Foltynie, University College London presents the Bydureon Phase III Trial at The Cure Parkinson’s Trust’s 2019 Autumn Research Update Meeting. Concepts Keywords Absolution ... Read more

November 29, 2019November 29, 2019

Dr Stephen Mullin – the GBA Parkinson’s Genotype

Parkinson's Disease Media

Publication date: Nov 28, 2019 Dr Stephen Mullin – the University of Plymouth presents the GBA Parkinson’s genotype, treatments in development and the need for trial participants. The Cure Parkinson’s ... Read more

November 28, 2019

Enabling Clinical Trials of Disease-Modifying Therapies for Huntington’s Disease

Huntington's Disease Media

Publication date: Nov 27, 2019 Lauren Byrne of University College London discusses how ultrasensitive biomarker detection technology is making a huge impact in the study of Huntington’s Disease at the ... Read more